Hirslanden Clinique La Colline is gaining new management - Press release
PDF | 114.54 KB
Gilles Rufenacht is to take over the management of Hirslanden Clinique La Colline as of 1 February 2019. He is replacing Stéphan Studer, who has been promoted to Regional Operating Officer (ROO) within the Hirslanden Private Hospital Group. Gilles Rufenacht will retain his previous role as hospital manager of Clinique des Grangettes. He will in future be supported by a deputy hospital manager: André Martin will take up this newly created job as of 1 March 2019.
Gilles Rufenacht (45 years old, married with three children) is a graduate of Ecole Hôtelière de Lausanne. He has worked in Clinique des Grangettes since 2000 and has been its hospital manager since 2008. As part of his work, he played a key role in the successful development of Clinique des Grangettes and the merger with Hirslanden Clinique La Colline. Since 2012, he has been president of Association des Cliniques Privées de Genève (Genève-Cliniques) and a member of the Academic Council of Haute Ecole de Santé (HEdS). In recognition of his dedicated service to the Geneva business network, the Fédération des Entreprises Romandes (FER) appointed him a member of its steering committee.
André Martin (56 years old, married) has been CEO of Leukerbad Clinic AG since 2016. He has also been CEO of Intuitive Therapeutics SA since 2013. Between 2008 and 2013, he was CEO of Clinique de Valère. With more than 15 years of experience in various hospitals in Western Switzerland, a Master's degree in Public Administration from the University of Lausanne and an INSEAD Certificate in management, André Martin has sound business knowledge in the hospital environment, which he will particularly bring to Clinique La Colline. In addition, he will lead cross-institutional projects within the two hospitals.
«The new organisational form with joint management for the two hospitals was chosen deliberately in order to facilitate successful mutual integration of Clinique La Colline and Clinique des Grangettes», Stéphan Studer, ROO of Hirslanden Group, emphasises. «The organisational form chosen will enable the realisation of strategic synergies between the two hospitals. Our aim is and remains the provision of high quality care to the population of Geneva.»
As you may recall, the two hospitals announced their merger on 4 September 2018 with the establishment of the joint company Hirslanden La Colline Grangettes SA. The Swiss Competition Commission approved the merger at the end of October 2018. The Hirslanden Private Hospital Group now has more than 18 hospitals across Switzerland. The addition of Clinique des Grangettes has strengthened its presence in Western Switzerland, giving it two hospitals in Geneva and two in Lausanne. The merger has also given Hirslanden a foothold in paediatrics and adolescent medicine thanks to the paediatrics department at Clinique des Grangettes, which includes a children's emergency department.
The Hirslanden Private Hospital Group consists of 18 hospitals in 11 cantons, many of which have an outpatient surgery centre and emergency department. The Group also operates 4 outpatient clinics, 17 radiology institutes and 5 radiotherapy institutes. As of 31 March 2018, the group had around 1,680 affiliated doctors and 9,635 employees, of whom 461 were permanently employed doctors. Hirslanden is the leading private hospital group and the largest medical network in Switzerland. In the 2017/18 financial year, the group generated turnover of 1,735 million Swiss francs. Between 1.01.2018 and 31.03.2018 the group treated more than 102,903 patients, amounting to a total of 473,343 inpatient days. In insurance terms, the patient mix consists of 47.9% basic, 29.7% semi-private, and 22.4% private insured patients.
The Hirslanden Private Hospital Group is synonymous with first-class medical care provided by highly qualified medical specialists with years of experience. As a system provider, Hirslanden stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Private Hospital Group was formed in 1990 through the merger of several Swiss private hospitals. Since 2007, it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.